批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2018/12/20 |
SUPPL-38(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/11/05 |
SUPPL-37(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/05/06 |
SUPPL-35(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2012/12/14 |
SUPPL-34(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2011/03/21 |
SUPPL-27(补充) |
Approval |
Manufacturing (CMC) |
N/A
|
|
|
2009/09/01 |
SUPPL-28(补充) |
Approval |
Supplement |
STANDARD
|
|
|
2008/07/08 |
SUPPL-26(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/03/08 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/07/23 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/12/31 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/07/17 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/04/03 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2001/05/25 |
ORIG-1(原始申请) |
Approval |
Type 5 - New Formulation or New Manufacturer |
STANDARD
|
|
|
与本品治疗等效的药品
活性成分:LEVOTHYROXINE SODIUM 剂型/给药途径:TABLET;ORAL 规格:0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium 治疗等效代码:AB1
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021210 |
001 |
NDA |
UNITHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2000/08/21
|
STEVENS J |
021301 |
001 |
NDA |
LEVOXYL |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2001/05/25
|
KING PHARMS |
021342 |
001 |
NDA |
LEVO-T |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2002/03/01
|
CEDIPROF INC |
076187 |
001 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2002/06/05
|
MYLAN |
021402 |
001 |
NDA |
SYNTHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2002/07/24
|
ABBVIE |
021116 |
001 |
NDA |
THYRO-TABS |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2002/10/24
|
ALVOGEN |
021137 |
001 |
NDA |
LEVOLET |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2003/06/06
|
GENUS LIFESCIENCES |
209713 |
001 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2019/01/18
|
LUPIN |
212399 |
001 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2020/10/19
|
ACCORD HLTHCARE |
207588 |
001 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2022/05/10
|
WATSON LABS TEVA |
211417 |
001 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2022/12/21
|
MACLEODS PHARMS LTD |
活性成分:LEVOTHYROXINE SODIUM 剂型/给药途径:TABLET;ORAL 规格:0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium 治疗等效代码:AB3
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021210 |
001 |
NDA |
UNITHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2000/08/21
|
STEVENS J |
021301 |
001 |
NDA |
LEVOXYL |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2001/05/25
|
KING PHARMS |
021342 |
001 |
NDA |
LEVO-T |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2002/03/01
|
CEDIPROF INC |
076187 |
001 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2002/06/05
|
MYLAN |
021116 |
001 |
NDA |
THYRO-TABS |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2002/10/24
|
ALVOGEN |
021137 |
001 |
NDA |
LEVOLET |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2003/06/06
|
GENUS LIFESCIENCES |
209713 |
001 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2019/01/18
|
LUPIN |
212399 |
001 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2020/10/19
|
ACCORD HLTHCARE |
207588 |
001 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2022/05/10
|
WATSON LABS TEVA |
活性成分:LEVOTHYROXINE SODIUM 剂型/给药途径:TABLET;ORAL 规格:0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium 治疗等效代码:AB1
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021210 |
002 |
NDA |
UNITHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2000/08/21
|
STEVENS J |
021301 |
002 |
NDA |
LEVOXYL |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2001/05/25
|
KING PHARMS |
021342 |
002 |
NDA |
LEVO-T |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2002/03/01
|
CEDIPROF INC |
076187 |
002 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2002/06/05
|
MYLAN |
021402 |
002 |
NDA |
SYNTHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2002/07/24
|
ABBVIE |
021116 |
002 |
NDA |
THYRO-TABS |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2002/10/24
|
ALVOGEN |
021137 |
002 |
NDA |
LEVOLET |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2003/06/06
|
GENUS LIFESCIENCES |
209713 |
002 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2019/01/18
|
LUPIN |
212399 |
002 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2020/10/19
|
ACCORD HLTHCARE |
207588 |
002 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2022/05/10
|
WATSON LABS TEVA |
211417 |
002 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2022/12/21
|
MACLEODS PHARMS LTD |
活性成分:LEVOTHYROXINE SODIUM 剂型/给药途径:TABLET;ORAL 规格:0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium 治疗等效代码:AB3
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021210 |
002 |
NDA |
UNITHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2000/08/21
|
STEVENS J |
021301 |
002 |
NDA |
LEVOXYL |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2001/05/25
|
KING PHARMS |
021342 |
002 |
NDA |
LEVO-T |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2002/03/01
|
CEDIPROF INC |
076187 |
002 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2002/06/05
|
MYLAN |
021116 |
002 |
NDA |
THYRO-TABS |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2002/10/24
|
ALVOGEN |
021137 |
002 |
NDA |
LEVOLET |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2003/06/06
|
GENUS LIFESCIENCES |
209713 |
002 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2019/01/18
|
LUPIN |
212399 |
002 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2020/10/19
|
ACCORD HLTHCARE |
207588 |
002 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2022/05/10
|
WATSON LABS TEVA |
活性成分:LEVOTHYROXINE SODIUM 剂型/给药途径:TABLET;ORAL 规格:0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium 治疗等效代码:AB1
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021210 |
003 |
NDA |
UNITHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2000/08/21
|
STEVENS J |
021301 |
003 |
NDA |
LEVOXYL |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2001/05/25
|
KING PHARMS |
021342 |
003 |
NDA |
LEVO-T |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2002/03/01
|
CEDIPROF INC |
076187 |
003 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2002/06/05
|
MYLAN |
021402 |
003 |
NDA |
SYNTHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2002/07/24
|
ABBVIE |
021116 |
003 |
NDA |
THYRO-TABS |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2002/10/24
|
ALVOGEN |
021137 |
003 |
NDA |
LEVOLET |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2003/06/06
|
GENUS LIFESCIENCES |
209713 |
003 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2019/01/18
|
LUPIN |
212399 |
003 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2020/10/19
|
ACCORD HLTHCARE |
207588 |
003 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2022/05/10
|
WATSON LABS TEVA |
211417 |
003 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2022/12/21
|
MACLEODS PHARMS LTD |
活性成分:LEVOTHYROXINE SODIUM 剂型/给药途径:TABLET;ORAL 规格:0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium 治疗等效代码:AB3
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021210 |
003 |
NDA |
UNITHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2000/08/21
|
STEVENS J |
021301 |
003 |
NDA |
LEVOXYL |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2001/05/25
|
KING PHARMS |
021342 |
003 |
NDA |
LEVO-T |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2002/03/01
|
CEDIPROF INC |
076187 |
003 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2002/06/05
|
MYLAN |
021116 |
003 |
NDA |
THYRO-TABS |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2002/10/24
|
ALVOGEN |
021137 |
003 |
NDA |
LEVOLET |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2003/06/06
|
GENUS LIFESCIENCES |
209713 |
003 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2019/01/18
|
LUPIN |
212399 |
003 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2020/10/19
|
ACCORD HLTHCARE |
207588 |
003 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2022/05/10
|
WATSON LABS TEVA |
活性成分:LEVOTHYROXINE SODIUM 剂型/给药途径:TABLET;ORAL 规格:0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium 治疗等效代码:AB1
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021210 |
004 |
NDA |
UNITHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2000/08/21
|
STEVENS J |
021301 |
004 |
NDA |
LEVOXYL |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2001/05/25
|
KING PHARMS |
021342 |
004 |
NDA |
LEVO-T |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2002/03/01
|
CEDIPROF INC |
076187 |
004 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2002/06/05
|
MYLAN |
021402 |
004 |
NDA |
SYNTHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2002/07/24
|
ABBVIE |
021116 |
010 |
NDA |
THYRO-TABS |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2002/10/24
|
ALVOGEN |
021137 |
004 |
NDA |
LEVOLET |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2003/06/06
|
GENUS LIFESCIENCES |
209713 |
004 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2019/01/18
|
LUPIN |
212399 |
004 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2020/10/19
|
ACCORD HLTHCARE |
207588 |
004 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2022/05/10
|
WATSON LABS TEVA |
211417 |
004 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2022/12/21
|
MACLEODS PHARMS LTD |
活性成分:LEVOTHYROXINE SODIUM 剂型/给药途径:TABLET;ORAL 规格:0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium 治疗等效代码:AB3
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021210 |
004 |
NDA |
UNITHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2000/08/21
|
STEVENS J |
021301 |
004 |
NDA |
LEVOXYL |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2001/05/25
|
KING PHARMS |
021342 |
004 |
NDA |
LEVO-T |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2002/03/01
|
CEDIPROF INC |
076187 |
004 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2002/06/05
|
MYLAN |
021116 |
010 |
NDA |
THYRO-TABS |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2002/10/24
|
ALVOGEN |
021137 |
004 |
NDA |
LEVOLET |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2003/06/06
|
GENUS LIFESCIENCES |
209713 |
004 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2019/01/18
|
LUPIN |
212399 |
004 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2020/10/19
|
ACCORD HLTHCARE |
207588 |
004 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2022/05/10
|
WATSON LABS TEVA |
活性成分:LEVOTHYROXINE SODIUM 剂型/给药途径:TABLET;ORAL 规格:0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium 治疗等效代码:AB1
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021210 |
005 |
NDA |
UNITHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2000/08/21
|
STEVENS J |
021301 |
005 |
NDA |
LEVOXYL |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2001/05/25
|
KING PHARMS |
021342 |
005 |
NDA |
LEVO-T |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2002/03/01
|
CEDIPROF INC |
076187 |
005 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2002/06/05
|
MYLAN |
021402 |
005 |
NDA |
SYNTHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2002/07/24
|
ABBVIE |
021116 |
004 |
NDA |
THYRO-TABS |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2002/10/24
|
ALVOGEN |
021137 |
005 |
NDA |
LEVOLET |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2003/06/06
|
GENUS LIFESCIENCES |
209713 |
005 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2019/01/18
|
LUPIN |
212399 |
005 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2020/10/19
|
ACCORD HLTHCARE |
207588 |
005 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2022/05/10
|
WATSON LABS TEVA |
211417 |
005 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2022/12/21
|
MACLEODS PHARMS LTD |
活性成分:LEVOTHYROXINE SODIUM 剂型/给药途径:TABLET;ORAL 规格:0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium 治疗等效代码:AB3
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021210 |
005 |
NDA |
UNITHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2000/08/21
|
STEVENS J |
021301 |
005 |
NDA |
LEVOXYL |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2001/05/25
|
KING PHARMS |
021342 |
005 |
NDA |
LEVO-T |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2002/03/01
|
CEDIPROF INC |
076187 |
005 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2002/06/05
|
MYLAN |
021116 |
004 |
NDA |
THYRO-TABS |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2002/10/24
|
ALVOGEN |
021137 |
005 |
NDA |
LEVOLET |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2003/06/06
|
GENUS LIFESCIENCES |
209713 |
005 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2019/01/18
|
LUPIN |
212399 |
005 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2020/10/19
|
ACCORD HLTHCARE |
207588 |
005 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2022/05/10
|
WATSON LABS TEVA |
活性成分:LEVOTHYROXINE SODIUM 剂型/给药途径:TABLET;ORAL 规格:0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium 治疗等效代码:AB1
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021210 |
006 |
NDA |
UNITHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2000/08/21
|
STEVENS J |
021301 |
006 |
NDA |
LEVOXYL |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2001/05/25
|
KING PHARMS |
021342 |
006 |
NDA |
LEVO-T |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2002/03/01
|
CEDIPROF INC |
076187 |
006 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2002/06/05
|
MYLAN |
021402 |
006 |
NDA |
SYNTHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2002/07/24
|
ABBVIE |
021116 |
011 |
NDA |
THYRO-TABS |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2002/10/24
|
ALVOGEN |
021137 |
006 |
NDA |
LEVOLET |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2003/06/06
|
GENUS LIFESCIENCES |
209713 |
006 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2019/01/18
|
LUPIN |
212399 |
006 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2020/10/19
|
ACCORD HLTHCARE |
207588 |
006 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2022/05/10
|
WATSON LABS TEVA |
211417 |
006 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2022/12/21
|
MACLEODS PHARMS LTD |
活性成分:LEVOTHYROXINE SODIUM 剂型/给药途径:TABLET;ORAL 规格:0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium 治疗等效代码:AB3
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021210 |
006 |
NDA |
UNITHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2000/08/21
|
STEVENS J |
021301 |
006 |
NDA |
LEVOXYL |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2001/05/25
|
KING PHARMS |
021342 |
006 |
NDA |
LEVO-T |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2002/03/01
|
CEDIPROF INC |
076187 |
006 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2002/06/05
|
MYLAN |
021116 |
011 |
NDA |
THYRO-TABS |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2002/10/24
|
ALVOGEN |
021137 |
006 |
NDA |
LEVOLET |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2003/06/06
|
GENUS LIFESCIENCES |
209713 |
006 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2019/01/18
|
LUPIN |
212399 |
006 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2020/10/19
|
ACCORD HLTHCARE |
207588 |
006 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2022/05/10
|
WATSON LABS TEVA |
活性成分:LEVOTHYROXINE SODIUM 剂型/给药途径:TABLET;ORAL 规格:0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium 治疗等效代码:AB1
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021210 |
007 |
NDA |
UNITHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2000/08/21
|
STEVENS J |
021301 |
007 |
NDA |
LEVOXYL |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2001/05/25
|
KING PHARMS |
021342 |
007 |
NDA |
LEVO-T |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2002/03/01
|
CEDIPROF INC |
076187 |
007 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2002/06/05
|
MYLAN |
021402 |
007 |
NDA |
SYNTHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2002/07/24
|
ABBVIE |
021116 |
005 |
NDA |
THYRO-TABS |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2002/10/24
|
ALVOGEN |
021137 |
007 |
NDA |
LEVOLET |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2003/06/06
|
GENUS LIFESCIENCES |
209713 |
007 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2019/01/18
|
LUPIN |
212399 |
007 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2020/10/19
|
ACCORD HLTHCARE |
207588 |
007 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2022/05/10
|
WATSON LABS TEVA |
211417 |
007 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2022/12/21
|
MACLEODS PHARMS LTD |
活性成分:LEVOTHYROXINE SODIUM 剂型/给药途径:TABLET;ORAL 规格:0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium 治疗等效代码:AB3
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021210 |
007 |
NDA |
UNITHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2000/08/21
|
STEVENS J |
021301 |
007 |
NDA |
LEVOXYL |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2001/05/25
|
KING PHARMS |
021342 |
007 |
NDA |
LEVO-T |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2002/03/01
|
CEDIPROF INC |
076187 |
007 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2002/06/05
|
MYLAN |
021116 |
005 |
NDA |
THYRO-TABS |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2002/10/24
|
ALVOGEN |
021137 |
007 |
NDA |
LEVOLET |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2003/06/06
|
GENUS LIFESCIENCES |
209713 |
007 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2019/01/18
|
LUPIN |
212399 |
007 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2020/10/19
|
ACCORD HLTHCARE |
207588 |
007 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2022/05/10
|
WATSON LABS TEVA |
活性成分:LEVOTHYROXINE SODIUM 剂型/给药途径:TABLET;ORAL 规格:0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium 治疗等效代码:AB1
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021301 |
008 |
NDA |
LEVOXYL |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2001/05/25
|
KING PHARMS |
021402 |
008 |
NDA |
SYNTHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2002/07/24
|
ABBVIE |
021137 |
008 |
NDA |
LEVOLET |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2003/06/06
|
GENUS LIFESCIENCES |
021342 |
012 |
NDA |
LEVO-T |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2003/12/08
|
CEDIPROF INC |
021116 |
012 |
NDA |
THYRO-TABS |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2004/12/07
|
ALVOGEN |
076187 |
012 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2006/12/13
|
MYLAN |
021210 |
012 |
NDA |
UNITHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2008/02/08
|
STEVENS J |
209713 |
008 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2019/01/18
|
LUPIN |
212399 |
008 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2020/10/19
|
ACCORD HLTHCARE |
207588 |
008 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2022/05/10
|
WATSON LABS TEVA |
211417 |
008 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2022/12/21
|
MACLEODS PHARMS LTD |
活性成分:LEVOTHYROXINE SODIUM 剂型/给药途径:TABLET;ORAL 规格:0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium 治疗等效代码:AB3
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021301 |
008 |
NDA |
LEVOXYL |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2001/05/25
|
KING PHARMS |
021137 |
008 |
NDA |
LEVOLET |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2003/06/06
|
GENUS LIFESCIENCES |
021342 |
012 |
NDA |
LEVO-T |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2003/12/08
|
CEDIPROF INC |
021116 |
012 |
NDA |
THYRO-TABS |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2004/12/07
|
ALVOGEN |
076187 |
012 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2006/12/13
|
MYLAN |
021210 |
012 |
NDA |
UNITHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2008/02/08
|
STEVENS J |
209713 |
008 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2019/01/18
|
LUPIN |
212399 |
008 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2020/10/19
|
ACCORD HLTHCARE |
207588 |
008 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2022/05/10
|
WATSON LABS TEVA |
活性成分:LEVOTHYROXINE SODIUM 剂型/给药途径:TABLET;ORAL 规格:0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium 治疗等效代码:AB1
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021210 |
008 |
NDA |
UNITHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2000/08/21
|
STEVENS J |
021301 |
009 |
NDA |
LEVOXYL |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2001/05/25
|
KING PHARMS |
021342 |
008 |
NDA |
LEVO-T |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2002/03/01
|
CEDIPROF INC |
076187 |
008 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2002/06/05
|
MYLAN |
021402 |
009 |
NDA |
SYNTHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2002/07/24
|
ABBVIE |
021116 |
006 |
NDA |
THYRO-TABS |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2002/10/24
|
ALVOGEN |
021137 |
009 |
NDA |
LEVOLET |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2003/06/06
|
GENUS LIFESCIENCES |
209713 |
009 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2019/01/18
|
LUPIN |
212399 |
009 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2020/10/19
|
ACCORD HLTHCARE |
207588 |
009 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2022/05/10
|
WATSON LABS TEVA |
211417 |
009 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2022/12/21
|
MACLEODS PHARMS LTD |
活性成分:LEVOTHYROXINE SODIUM 剂型/给药途径:TABLET;ORAL 规格:0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium 治疗等效代码:AB3
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021210 |
008 |
NDA |
UNITHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2000/08/21
|
STEVENS J |
021301 |
009 |
NDA |
LEVOXYL |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2001/05/25
|
KING PHARMS |
021342 |
008 |
NDA |
LEVO-T |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2002/03/01
|
CEDIPROF INC |
076187 |
008 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2002/06/05
|
MYLAN |
021116 |
006 |
NDA |
THYRO-TABS |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2002/10/24
|
ALVOGEN |
021137 |
009 |
NDA |
LEVOLET |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2003/06/06
|
GENUS LIFESCIENCES |
209713 |
009 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2019/01/18
|
LUPIN |
212399 |
009 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2020/10/19
|
ACCORD HLTHCARE |
207588 |
009 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2022/05/10
|
WATSON LABS TEVA |
活性成分:LEVOTHYROXINE SODIUM 剂型/给药途径:TABLET;ORAL 规格:0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium 治疗等效代码:AB1
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021210 |
009 |
NDA |
UNITHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2000/08/21
|
STEVENS J |
021301 |
010 |
NDA |
LEVOXYL |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2001/05/25
|
KING PHARMS |
021342 |
009 |
NDA |
LEVO-T |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2002/03/01
|
CEDIPROF INC |
076187 |
009 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2002/06/05
|
MYLAN |
021402 |
010 |
NDA |
SYNTHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2002/07/24
|
ABBVIE |
021116 |
007 |
NDA |
THYRO-TABS |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2002/10/24
|
ALVOGEN |
021137 |
010 |
NDA |
LEVOLET |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2003/06/06
|
GENUS LIFESCIENCES |
209713 |
010 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2019/01/18
|
LUPIN |
212399 |
010 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2020/10/19
|
ACCORD HLTHCARE |
207588 |
010 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2022/05/10
|
WATSON LABS TEVA |
211417 |
010 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2022/12/21
|
MACLEODS PHARMS LTD |
活性成分:LEVOTHYROXINE SODIUM 剂型/给药途径:TABLET;ORAL 规格:0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium 治疗等效代码:AB3
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021210 |
009 |
NDA |
UNITHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2000/08/21
|
STEVENS J |
021301 |
010 |
NDA |
LEVOXYL |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2001/05/25
|
KING PHARMS |
021342 |
009 |
NDA |
LEVO-T |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2002/03/01
|
CEDIPROF INC |
076187 |
009 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2002/06/05
|
MYLAN |
021116 |
007 |
NDA |
THYRO-TABS |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2002/10/24
|
ALVOGEN |
021137 |
010 |
NDA |
LEVOLET |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2003/06/06
|
GENUS LIFESCIENCES |
209713 |
010 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2019/01/18
|
LUPIN |
212399 |
010 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2020/10/19
|
ACCORD HLTHCARE |
207588 |
010 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2022/05/10
|
WATSON LABS TEVA |
活性成分:LEVOTHYROXINE SODIUM 剂型/给药途径:TABLET;ORAL 规格:0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium 治疗等效代码:AB1
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021210 |
010 |
NDA |
UNITHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2000/08/21
|
STEVENS J |
021301 |
011 |
NDA |
LEVOXYL |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
Yes |
AB1 |
2001/05/25
|
KING PHARMS |
021342 |
010 |
NDA |
LEVO-T |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2002/03/01
|
CEDIPROF INC |
076187 |
010 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2002/06/05
|
MYLAN |
021402 |
012 |
NDA |
SYNTHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2002/07/24
|
ABBVIE |
021116 |
008 |
NDA |
THYRO-TABS |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB1 |
2002/10/24
|
ALVOGEN |
021137 |
011 |
NDA |
LEVOLET |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2003/06/06
|
GENUS LIFESCIENCES |
209713 |
011 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2019/01/18
|
LUPIN |
212399 |
011 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2020/10/19
|
ACCORD HLTHCARE |
207588 |
011 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2022/05/10
|
WATSON LABS TEVA |
211417 |
011 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB1 |
2022/12/21
|
MACLEODS PHARMS LTD |
活性成分:LEVOTHYROXINE SODIUM 剂型/给药途径:TABLET;ORAL 规格:0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium 治疗等效代码:AB3
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021210 |
010 |
NDA |
UNITHROID |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2000/08/21
|
STEVENS J |
021301 |
011 |
NDA |
LEVOXYL |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
Yes |
AB3 |
2001/05/25
|
KING PHARMS |
021342 |
010 |
NDA |
LEVO-T |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2002/03/01
|
CEDIPROF INC |
076187 |
010 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2002/06/05
|
MYLAN |
021116 |
008 |
NDA |
THYRO-TABS |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
Yes |
No |
AB3 |
2002/10/24
|
ALVOGEN |
021137 |
011 |
NDA |
LEVOLET |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2003/06/06
|
GENUS LIFESCIENCES |
209713 |
011 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2019/01/18
|
LUPIN |
212399 |
011 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2020/10/19
|
ACCORD HLTHCARE |
207588 |
011 |
ANDA |
LEVOTHYROXINE SODIUM |
LEVOTHYROXINE SODIUM |
TABLET;ORAL |
0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium |
Prescription |
No |
No |
AB3 |
2022/05/10
|
WATSON LABS TEVA |